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http://www.trialsjournal.com/content/15/1/181STUDY PROTOCOL Open AccessComparison of face-to-face versus email guided
self-help for binge eating: study protocol for a
randomised controlled trial
Paul E Jenkins1,2*, Amy Luck1, Alison Burrows1 and Nicky Boughton1Abstract
Background: Guided self-help is a recommended first-step treatment for bulimia nervosa, binge eating disorder
and atypical variants of these disorders. Further research is needed to compare guided self-help that is delivered
face-to-face versus via email.
Methods/Design: This clinical trial uses a randomised, controlled design to investigate the effectiveness of
providing guided self-help either face-to-face or via e-mail, also using a delayed treatment control condition.
At least 17 individuals are required per group, giving a minimum N of 51.
Discussion: Symptom outcomes will be assessed and estimates of cost-effectiveness made. Results are proposed
to be disseminated locally and internationally (through submission to conferences and peer-reviewed journals),
and will hopefully inform local service provision. The trial has been approved by an ethics review board and
was registered with ClinicalTrials.gov NCT01832792 on 9 April 2013.
Keywords: Guided self-help, Eating disorders, Email, Clinical trialBackground
Psychological therapy is the recommended treatment for
eating disorders characterised by recurrent binge eating,
with evidence-based self-help recommended as a first
step of treatment [1]. However, few studies have looked
at how best to deliver this form of treatment, although
outcomes and treatment adherence appear better when
guidance is available from a healthcare professional (for
example, [2-4]), known as guided self-help or GSH. Fur-
thermore, GSH has demonstrated particular cost-
effectiveness, even when highly trained clinicians are used
to administer the treatment [5], and a number of other
RCTs have supported the utility of cognitive behaviour
therapy (CBT)-based self-help in the treatment of recur-
rent binge eating (see [6] for a review). Typically this has
been delivered face-to-face, but email-assisted therapy has
been suggested as a helpful way of obtaining professional
treatment without the need for face-to-face contact that is
popular with patients and therapists [7]. It is potentially* Correspondence: pej106@gmail.com
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unless otherwise stated.less costly for health service providers, and may be more
acceptable to certain subgroups of patients, for example,
those who might not wish to attend face-to-face appoint-
ments [8]. As eating disorders services often cover large
populations, many individuals are required to make a long
commute in order to attend appointments (for example,
[9]) and so treatments delivered over the Internet can cir-
cumvent many of the difficulties associated with this. Simi-
larly, treatments that require less face-to-face contact can
be perceived as more empowering (for example, [10]) and
are more cost-effective [11].
Guided self-help also has potential beyond specialist
eating disorders (ED) services. Högdahl et al. [12] argue
that bibliotherapy with email support has a similar con-
tent but is less costly than CBT and other Internet-based
approaches. They argue that if effectiveness of such an
approach can be established, it can be used in both spe-
cialist and non-specialist settings “due to minimal ther-
apist training and low cost” (p. 38; see also [13]). In the
UK, for example, Improving Access to Psychological
Therapies (IAPT) is a programme within the National
Health Service (NHS) that supports delivery of recom-
mended guidelines for anxiety and depression and hasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and long-term physical health conditions [14]. Guided
self-help significantly contributes to the interventions
delivered by IAPT services [14], although its application
to eating disorders (and adults in particular) is not uni-
form. Given that EDs are associated with significant dis-
ability and cost-of-illness (for example, [15]) - both areas
targeted by the IAPT programme- the IAPT service may
be well-placed to support the delivery of GSH to suf-
ferers of some of these disorders (for example, see [16]).
Although limited data exist on the effectiveness of GSH in
primary care, with significant early termination of treat-
ment (for example, [17]), rates of bulimia nervosa (BN)
and binge eating disorder (BED) appear to be amongst the
highest seen in affected groups. Only a minority of suf-
ferers seek professional help and therefore being able to
offer a variety of methods of delivering help may go fur-
ther to reducing the devastating impact of these illnesses.
A previous randomised controlled trial (RCT) [18] com-
pared different forms of guidance and found that, although
face-to-face guidance was superior to both telephone-
based guidance and self-help with minimal guidance, tele-
phone contact demonstrated promising results and may
be useful when face-to-face contact proves difficult to ar-
range. A more recent RCT [19] compared Internet-based
GSH to a waiting list control for individuals with BN or
BED. A self-help book [20] was provided, and associated
guidance took the form of email contact with a graduate
psychology student. The treatment condition resulted in
significant symptom improvement compared to a waiting
list control. This was maintained at six-month follow-up
and appeared comparable to results of face-to-face treat-
ment in other studies, although no direct test of this
was carried out. A recent study by Wagner et al. [21]
compared GSH and an Internet-based CBT program with
therapist support in a sample of 155 females with BN or
atypical BN. The two treatments were found to be com-
parableand effective in reducing ED symptoms at end-of-
treatment and follow-up up to 18 months.
In addition to documented efficacy in favour of self-
help, there is some emerging evidence that GSH for
normal-weight binge eating disorders (that is, BN and
BED) can be provided through methods other than face-
to-face contact with a therapist (the term ‘therapist’ is pre-
ferred here; see below). There have, however, been few
controlled studies directly assessing and comparing the ef-
fectiveness of different treatment modalities, and a recent
review concluded that there exists a “lack of direct com-
parisons of Internet-based treatments to face-to-face treat-
ments” for eating disorders [22, p. 549]. Only a small
number of studies have compared different forms of guid-
ance in GSH, and only one study has looked at email
support compared to a control condition [19]. One RCT
comparing Internet-delivered CBT versus face-to-facegroup CBT [22] is currently ongoing. Further research
is needed to identify the efficacy and feasibility of diffe-
rent forms of guidance in order to develop cost-effective
and beneficial treatments that can be adapted to patient
need.
Objectives and hypotheses of the RCT
The overall aim of the trial is to evaluate whether ther-
apist support within GSH can be as effective when deliv-
ered via email as when delivered face-to-face. In this
paper, we detail the design and methods of the current
trial, and clarify the four main aims of the study. Specific-
ally, these are to: (1) compare the effectiveness of face-to-
face versus email GSH during treatment and at follow-up;
(2) determine relative attrition and drop-out across the
two treatments; (3) look at predictors of outcome in
GSH (see below); and (4) determine the relative cost-
effectiveness of these two treatments. The study also em-
ploys a waiting list control condition. The current paper
describes the protocol on which the clinical trial is based,
in line with suggested guidance (for example, [23]).
In terms of the primary outcome measure, it is ex-
pected that both treatment conditions will be superior
to the waiting list control condition (for example, [4,18]).
Although there is a limited amount of evidence in eating
disorders, it is hypothesised that both treatments (face-to-
face and email GSH) will be comparable in terms of effect-
iveness (for example, [24]) in reducing binge eating
frequency (see also [21]). It is expected that similar re-
sults will be found with secondary outcome measures,
drop-out and cost-effectiveness, although these variables
have not yet been studied in detail in this way.
Methods and design
Study setting and trial design
The trial is a three-arm, individually randomised, con-
trolled trial with two active treatments and a waiting list
control. The study is being conducted within Oxford
Health NHS Foundation Trust in the United Kingdom.
The Eating Disorders Service covers a population of
around 1.6 million adults and has three sites, each of
which is recruiting participants as part of the trial. Par-
ticipants are randomly assigned (using a random num-
ber generator) to one of three conditions: face-to-face
GSH, email GSH or a waiting list control condition. Each
condition lasts 12 weeks, and follow-up evaluations
are conducted six months post-treatment. Ethical ap-
proval for this Trial was obtained from NRES Com-
mittee South Central-Oxford B, National Research Ethics
Service, Reference: 13/SC/0217. The trial is registered with
ClinicalTrials.gov, no. NCT01832792. Participants receive
verbal and written information before consenting to the
study, are asked to indicate written consent (after at least
24 hours to consider this), and are instructed of their right
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compliance with the Declaration of Helsinki and Good
Clinical Practice (GCP) and will be reported in line with
Consolidated Standards of Reporting Trials (CONSORT)
guidance.
Eligibility criteria
To be eligible for participation, individuals registered
with a General Practitioner covered by Oxford Health
NHS Foundation Trust must: (1) demonstrate regular
binge eating (defined as either subjective or objective bu-
limic episodes) in the context of an eating disorder; and
(2) be aged 17.5 or older. Participants are excluded from
the trial if they reported any of the following: (1) body
mass index (BMI) < 18.5; (2) recent rapid weight loss
(defined at >1 kg/week); (3) any major medical condition
that might interfere significantly with treatment; (4)
current excessive drug or alcohol use; and (5) active and
untreated psychosis or severe depression. Other contra-
indications to GSH (such as developmental disability
that would impair the ability to participate in the treat-
ment, or severe and complicated EDs) also represent
exclusion criteria.
Participant information sheets
Participant Information Sheets were approved by the
Research Ethics Committee (REC), and provide an over-
view of the study for potential participants. Researchers
are also on hand to explain the information contained
in the information sheet and to ensure fully informed
consent, documented with signed consent forms. Par-
ticipants are not deceived in any way. Readability of
information sheets was also considered and assessed
using the SMOG Grading index [25]. The SMOG was
calculated using an online calculator developed by its
author (http://www.harrymclaughlin.com/SMOG.htm)
and can generate equivalent grade levels for compre-
hension, which can also be categorised in line with the
United States Department of Health and Human Services
(USDHHS) standards (for example, [26]). SMOG levels
and equivalent classifications and school ages for the par-
ticipant materials used in the present study are reported
in Table 1.Table 1 Readability estimates for participant information
sheets
Material SMOG
score
USDHHS
classification
British school age
equivalent
Participant
information sheet
10.27 Difficult 15 to 17 years
Consent form 10.19 Difficult 15 to 17 years
Email security
information sheet
9.24 Average 12 to 15 yearsInterventions
All eligible patients are offered participation in the trial
following a team discussion within the Eating Disorders
Service (EDS) and are then randomly assigned to one of
the three conditions. This involves meeting with one
member of the research team who will go through the
trial protocol and information sheets. This is not the pa-
tient’s individual clinician, but the appointment can poten-
tially occur directly before or after a planned appointment
if this is more convenient for the participant. This helps
ensure completion of questionnaires and enables the par-
ticipant to ask any questions directly relating to the trial.
If individuals decide not to participate in the trial, they are
offered treatment as usual.
Both GSH interventions are based on a self-help treat-
ment [20,27] that has documented efficacy, and a copy
of the book is provided to patients. The treatment is
“program-led” [28]; that is, the aim of the therapist is to
support the patient in adhering to the principles of the
book, and thus does not require extensive clinical train-
ing. The treatment is designed so that non-specialist
therapists can readily administer this intervention [29].
Face-to-face GSH
This treatment follows the self-help manual, Overcoming
Binge Eating [20,27], and provides 10 sessions of face-to-
face therapist care, with each session lasting 20 to 25 mi-
nutes. The first session may last longer than this, due to
a need to review since the patient was last seen at the
EDS and to allow the patient more time to socialise to
treatment (see [28]). Guidance for the provision of GSH
has been provided in Fairburn [28], and 10 sessions are
provided over a period of 12 weeks. There is no specific
guidance about the frequency of sessions, although the
initial sessions are recommended to be at least weekly
with the remaining sessions being adapted to suit the pa-
tient’s progress [28]. A typical format might be to have
the first eight sessions weekly, with the remaining two
occurring over the following month (that is, fortnightly).
The second edition of the book in particular [27] might
be considered as ‘multicomponent GSH’ as it has been
based on Cognitive Behaviour Therapy-Enhanced (CBT-E)
[30] and designed to address many core elements of an
eating disorder, including topics such as self-monitoring,
psychoeducation and regular weighing. The support pro-
vided in this RCT is, adopting the taxonomy suggested by
Glasgow and Rosen [31], likely to fall somewhere between
‘therapist-administered’ and ‘minimal contact’. A more re-
cent paper [32] has elaborated further on this taxonomy,
suggesting that the form of GSH used here is best de-
scribed as ‘minimal contact therapy’ as opposed to ‘therap-
ist-administered’, the latter being where self-help material
“augments the impact of a standard therapy” (p. 90,). The
recent review of Farrand and Woodford [33] found a lack
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suggested by Glasgow and Rosen [31] (and the more up-
dated modifications from Newman et al. [32]) might be
difficult to determine a priori. Many evaluations of self-
help treatment have considered both of these categories
together under the wider umbrella of ‘GSH’ and, while the
lack of definition regarding the degree of involvement
from professionals is a shortcoming of the existing lit-
erature [33], it is hoped that a retrospective assess-
ment of this can be made in the current study. It would
be interesting to look at the content of GSH sessions
retrospectively to consider the degree of support (that is,
‘therapist-administered’ or ‘minimal contact’) as a pos-
sible moderator of outcome. In terms of treatment in
the current study, GSH was devised by the developer
to involve a therapist, but to a lesser degree than in con-
ventional CBT (see [28]). The treatment was designed to
be used by non-specialist therapists who help the patient
follow the GSH programme [29] by providing support, en-
couragement and monitoring of progress. Therapists also
discuss goals and elements of the programme identified
by patients as those that they wish to raise (for example,
parts they donot understand, disagree with or parts that
are not especially relevant), as well as potential solutions.
Of note, the term ‘therapist’ is used here to refer to those
individuals on the ‘professional side’ of the patient-therapist
dyad. However, some authors (for example, [34,35]) have
argued that use of this term in self-help could set up certain
expectations about the treatment that might hamper pro-
gress; thus, terms such as ‘guide’ and ‘facilitator’ have alter-
natively been used. As in other treatments and manuals the
precise term used could be modified to suit the individual
setting (for example, see [36]).
Email supported GSH
This treatment involves patient-therapist contact via e-
mail. Patients are advised to follow the treatment closely
(which is divided into ‘steps’) and instructed to contact
the therapist at least once a week, and can receive feed-
back up to twice a week for a period of 12 weeks [19].
Email is the preferred medium for all communication,
with face-to-face and telephone appointments occurring
at a minimum. The one exception to this is that the first
appointment is always conducted in person so that the
patient can meet their therapist, receive a copy of the
manual, be weighed at the clinic and so on. As sparse
guidance exists on how best to implement email sup-
ported GSH, the treatment has been conceived firstly to
parallel the face-to-face condition (see above); for ex-
ample, contact is less frequent towards the end of the
sessions. We have, secondly, followed the methodology
of Ljotsson et al. [19] as this was the first example of
providing GSH with the current manual with email sup-
port. Participants could (although this is not an exclusivelist): get feedback on homework and progress; ask ques-
tions; and receive guidance regarding the self-help pro-
gram. A more recent study [12] has described a similar
intervention, although less detail is reported on the exact
nature of support. The focus of supervision and the
practice of treatment were to follow the guidelines of
the therapist’s manual [28]. In the current study, thera-
pists are advised to follow similar guidelines to the face-
to-face condition. For example, therapists will still aim
to discuss problems, identify solutions and monitor pro-
gress; the treatment is proposed to be delivered in a
similar manner, but via the medium of email. The focus
in both treatment conditions is on the eating disorder,
and therapists may only address other issues if they are
of “immediate relevance to the binge eating problem”
([28], p. 9). Email can be sent securely by both patient
and therapist although patients will have to agree to
download a software package from Cisco and create a
password (this is optional, although it enhances data se-
curity). Identification of any significant increased risk
(for example, medical, suicidal) would prompt a tele-
phone call or face-to-face meeting from the therapist.
Delayed treatment condition
The delayed treatment condition lasts 12 weeks, and
data obtained from this period serve as waiting list con-
trol conditions. As at other stages of treatment, if, at re-
view, participants wish to opt out of the study they will
receive treatment as usual. There is no six-month follow-
up for this condition.
Primary and secondary outcomes
The primary outcome will be frequency of objective
bulimic episodes, as assessed by the Eating Disorder
Examination Questionnaire (EDE-Q) (see below). Compar-
isons will be made between pre-treatment, post-treatment
and follow-up in the intervention groups. Secondary out-
come measures include overall eating psychopathology,
other ED behaviours, such as self-induced vomiting, psy-
chological distress, self-esteem, functional impairment and
healthcare usage, assessed by self-report (see below). Some
of these variables (for example, severity of ED psychopath-
ology) will be considered as predictors of outcome, as
well as considered aspossible mediating or moderating
variables, such as therapeutic alliance or type of thera-
peutic support.
Assessments and timeline
All patients are assessed by the EDS following initial re-
ferral to the service. This is a full clinical assessment and
will identify current symptoms as well as aspects related
to comorbidity, risk and so on. For example, if patients
indicate on self-report questionnaires that they are a risk
to themselves or others, the clinician will discuss this
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trial they meet with one of the research team to give
written consent. The assessment procedure is outlined
in Table 2.
Data from the following measures will be collected:
The EDE-Q v6.0; [37] is a self-report questionnaire
that assesses eating disorder symptoms and has good
psychometric properties [38]. Participants rate how fre-
quently they have experienced symptoms (both attitu-
dinal and behavioural) of an ED over the last month on
a 0 to 6 scale (ranging from “no days” to “every day”).
The Clinical Outcomes in Routine Evaluation-Outcome
Measure (CORE-OM; [39]) is a self-report measure of
general psychological distress. Thirty-four items assess
symptoms over the preceding week and are rated on a
five-point frequency scale (from “not at all” to “most or all
of the time”), which can generate a global score indicating
overall functioning. Its utility in eating disorders has been
demonstrated [40].
The Rosenberg Self-Esteem Scale (RSES; [41]) comprises
10 items that measure global self-esteem. Responses are
given on a four-point scale from 1 (“strongly agree”) to 4
(“strongly disagree”), with half of the items reverse-scored.
The Clinical Impairment Assessment (CIA; [42]) is a
16-item self-report measure assessing psychosocial im-
pairment resulting from ED symptoms. Participants are
asked to consider the preceding 28 days and to indicate to
what degree symptoms of an ED have affected differentTable 2 Schedule for assessment
Measure Baseline Session 3 End-of-
treatment
(12 weeks)
Six-month
follow-up
Self-report
Demographics form X
Contact information X
EDE-Q X X X
CORE-OM X X X
RSES X X X
CIA X X X
Helping alliance
questionnaire
X X
Healthcare usage
questionnaire
X X X
Completed by
therapist
Weight/BMI X X X
Therapist time
questionnaire
X X
Helping alliance
questionnaire
X X
BMI, body mass index; CIA, Clinical Impairment Assessment; CORE-OM, Clinical
Outcomes in Routine Evaluation - Outcome Measure; EDE-Q, Eating Disorder
Examination Questionnaire; RSES, Rosenberg Self-Esteem Scale.areas of their life. Responses range from “Not at all” to
“A lot” (scored from 0 to 3), and a total score (0 to 48)
can be calculated giving an overall indication of functional
impairment. The CIA has demonstrated acceptable psy-
chometric properties across a range of samples [43].
The Helping Alliance questionnaire (HAq-II; [44]) is a
19-item measure of therapeutic alliance, showing good
psychometric properties. It comprises both positive and
negative items (which are reverse-scored), and includes
both a patient- and therapist-version. Statements regard-
ing the therapeutic alliance are rated from 1 (“strongly
disagree”) to 6 (“strongly agree”). A mean score is calcu-
lated by adding up all items (reverse-scoring as appro-
priate), calculating a mean, and then multiplying this by
19 (which should be identical to the total score if all
items are completed). Thus, scores range from 19 to 114
(with higher scores indicating better alliance). It has the
advantage of assessing alliance independent of symptom
improvement and has been used in previous ED treat-
ment studies (for example, [45]).
In addition, a measure assessing healthcare use devel-
oped specifically for this study will be given (see Additional
file 1). This will be administered with the standard pack
of questionnaires (that is, at start-of-treatment, end-
of-treatment and follow-up) for individuals who con-
sent to the study. An estimate of cost effectiveness will
be made by monitoring resource use directly associated
with different treatment conditions (for example, therapist
time spent providing care). The proportion of binge-free
days (estimated through the EDE-Q) will also be used
to estimate cost effectiveness (for example, [46]). Therap-
ist time will be estimated using a simple checklist of time
spent engaged in treatment-related activities. The mea-
sures listed should allow comparison with other studies
[33] and also overcome some of the shortcomings in
previous studies, such as limited estimates of cost-
effectiveness. Self-report measures may also limit obser-
ver bias, although this may be open to subject bias. The
lack of a structured clinical interview (for example, the
Eating Disorder Examination) is also a shortcoming, al-
though patients are screened on the basis of meeting cri-
teria for an eating disorder, following an interview with an
experienced clinician.
Sample size
A power calculation (using an α(two-tailed) of 0.05, an an-
ticipated effect size of 1.0 and a desired power of 0.8) sug-
gested that a minimum number of 17 individuals per
group [47], thus a minimum N of 51 is required. This was
based on the findings of Ljotsson et al. [19], who reported
a reduction in Global EDE-Q scores during self-help treat-
ment of 1.1 (SD = 0.9). Notable variability in effect sizes
for GSH treatment has been reported, with a recent sys-
tematic review of self-help interventions finding an overall
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ies [33] and another [48] citing effect sizes for the fre-
quency of binge eating ranging from .03 to 2.68. Effect
sizes in such studies have been shown to be affected by
factors such as level of pathology, sample (for example,
community vs. clinical), and length of follow-up [33].
Therefore, we are aiming for a minimum N of 51, but
ideally closer to 44 per group [47] to account for this vari-
ability and to minimise the risk of the study being under-
powered. Thus, a minimum overall recruitment sample of
102 is sought, estimating dropout at 50%, slightly less than
the 55% reported by Loeb et al. [3] and higher than the
approximately 23 % reported by Ljotsson et al. [19]. Attri-
tion rate has been considered as an important factor in
evaluating such trials [48]. Therefore, in the current study,
an attempt is made to more clearly define individuals who
do not complete treatment, for example, noting at what
point participants ceased treatment (for example, [49]).
Allocation
Participants who have given written consent to participate
will be randomly assigned to a waiting list, face-to-face
GSH, or email GSH condition, with a 1:1:1 allocation as
per a computer-generated random number sequence.
Numbers are stratified (for example, 0 to 0.333) and cor-
respond to allocation to a treatment arm. If participants in
the waiting list condition wish to remain in the trial, they
will then be randomised to one of the two treatment con-
ditions using the same method, but with a 1:1 allocation.
In order to further enhance allocation concealment, the
allocation for the first cohort of cases (the number is not
disclosed here) has been determined a priori. If more indi-
viduals than this are recruited, the procedure will be re-
peated. Reviews have highlighted unclear randomisation
procedures in many RCTs [33], and this method should
limit predictability of allocation due to use of “a random
and unpredictable assignment sequence” ([50]; see also
[51]). Although this was conducted by the Chief Investiga-
tor (CI) (rather than an external researcher), sequence
generation was completed prior to the first participant
being recruited and participants are allocated only after
full informed consent is received. In line with GCP guid-
ance, full consent is obtained at least 24 hours after
meeting with a member of the research team, and thus
treatment allocation is not known at the time of recruit-
ment, keeping allocation concealed until treatment is
assigned [50].
Data collection
Data from the EDE-Q provide the primary outcome
variable - binge eating frequency. Secondary variables in-
clude compensatory behaviours (for example, self-induced
vomiting), and ED psychopathology, as well as constructs
assessed by the other measures (self-esteem, psychologicaldistress, functional impairment). Weight and BMI are not
outcome variables, but may be included in analyses, for ex-
ample, to give demographic information or as covariates.
Other routine demographic information (for example, eth-
nicity) will also be recorded. Participants are asked to
complete self-report measures (mailed or otherwise given
by hand) at start-of-treatment, end-of-treatment and
six-month follow-up (with the exception of the HAq-II;
see Table 2). Data will be stored on a secure computer
server and analysed with computer statistics software (for
example, SPSS IBM Corporation, Armonk, NY, USA).
Oxford is the lead site for data coordination. In order to
promote data quality, data will be examined for impossible
values and a sample of electronic data (around 10%) will
be double-checked by another researcher with raw data.
Blinding is not used in this study, and so an emphasis on
appropriate outcome measurement and allocation con-
cealment is crucial [50,51].
Statistical methods
Regarding the primary aim - comparing active treatment
and control condition - results will be analysed using
analysis of variance and t-tests. Effect sizes will also
be assessed, and expressed appropriately (for example,
Cohen’s d). Logistic regression analyses will look at pre-
dictors of outcome, and potential mediators and moder-
ators might also be considered. However, a number of
existing studies addressing this issue have been under-
powered [33] so this remains an important consider-
ation. Differences in outcome variables will be analysed
(for example, through χ2, regression) to examine attrition/
drop-out. In terms of cost-effectiveness, analyses will be
conducted based on data obtained through the health util-
isation questionnaire, therapist time questionnaire and
measures of functional impairment (CIA) and ED symp-
toms (EDE-Q).
Therapists, training and supervision
All therapists will treat patients in both conditions, and
comprise individuals from a number of professions, such
as psychology and nursing. All have experience working
with individuals with eating disorders but, in line with
the suggestions regarding GSH (for example, [28]), they
are not particularly experienced in providing psycho-
logical therapy. Therapists in the current study comprise
both those with a professional healthcare qualification
(for example, nursing) and paraprofessionals (for example,
support workers, health care assistants), all of whom have
at least an undergraduate degree plus one year of experi-
ence working in mental health care. The term ‘therapist’ is
used here for simplicity to encompass all of those provi-
ding treatment within the trial. Fuller details of the thera-
pists involved will be reported following study completion,
in part due to the duration of the study and probability
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study; therefore, it is impossible to say at this point pre-
cisely who will comprise the personnel.
The training and background of therapists has also
been identified as an issue in therapist-administered
treatments [52-54]. In the current trial, all therapists are
specifically trained in the use of GSH, which involves ex-
tensive reading of the book, consultation of the therapist
manual and supervision with the CI, a clinical psycholo-
gist experienced in the provision and supervision of
GSH. As in the original effectiveness study [29], supervi-
sion is closer for a therapist’s first few cases. Therapists
are recruited from the local NHS (Mental Health) Trust
and no prior experience in working with EDs is required.
Most are likely to be recruited from the Eating Disorders
Service providing the treatment, although therapists
from other services (for example, Child and Adolescent
Mental Health Services(CAMHS)) have expressed inter-
est. Although research has found mixed results (includ-
ing some finding no differences in clinical outcomes)
when considering different ‘types’ of therapists, ther-
apist factors have been found to be important, even
in Internet-delivered interventions (for example, [55]),
and both research and clinical practice may benefit
from a focus on “what the therapist actually does” [56],
p. 282. To this end, clinical notes (including email tran-
scripts) are regularly reviewed by the supervisor, in part
also to maintain treatment fidelity.
An ‘understudy’ system is in place (for example, [30])
in case of therapist absence, although this is recom-
mended to be avoided wherever possible. All therapists
are instructed to familiarise themselves completely with
the treatment manual and to read specific preparatory
material (such as the therapist manual). Therapists meet
with the CI prior to the start of the trial in order to dis-
cuss any major concerns or to raise any questions. Their
adherence to the protocol will be monitored through
supervision and meetings with the Chief Investigator.
Therapists keep electronic notes of each session, in
addition to a record of direct time spent on patient care
(for cost-effectiveness evaluation). Patients are allocated
to therapists according to site and therapist availability.
Dr. Jenkins serves as the overall supervisor for the
study as well as the on-site supervisor for one of the lo-
cations (Oxford). Other locations are supervised on-site
by other senior psychologists with extensive experience
in eating disorders. In order to pilot a novel medium of
supervision, therapists receive cross-site supervision
from Dr. Jenkins via an online, secure, discussion forum.
Questions and responses can be posted such that all
therapists involved in the study have access to this
whenever they have a secure Internet connection. This
also allows detailed analysis of the content of supervision
for evaluation purposes.Data monitoring
Research governance The local REC will review the
project at least annually, including safety and progress
reports from the principal investigator. Any significant
modifications to the protocol will be submitted for ap-
proval to the REC prior to implementation and in ac-
cordance with policies. Case report forms (CRFs) are
also kept, in line with GCP principles.
Protocol adherence and untoward events Non-negligent
indemnity is provided by Oxford Health NHS Foundation
Trust, which is responsible for monitoring the safety of
any data obtained and also acts as the study sponsor. Data
are kept on a secure server, which requires password ac-
cess. The Trust monitors the study and has authority to
review the protocol and suspend the trial, and also en-
sures that the study is being conducted according to
the protocol. Any adverse events identified in the study
are immediately reported to the Trust. A pilot study will
be conducted to evaluate both the methodology and to
give a more accurate estimate of sample size requirement
(see [57]). A new edition of the self-help book [27] has re-
cently been released and an amendment to the protocol
submitted to the local REC has permitted use of the sec-
ond edition with all but the first 15 individuals, who will
form a pilot study.
Trial closure The end of the trial will be the date of the
last follow-up of the last participant.
Confidentiality All study-related information will be
stored securely, with participant information kept in locked
file cabinets in areas with restricted access. Unique partici-
pant identifiers will be used (rather than names) to main-
tain confidentiality, although a document linking these two
identifiers will be kept in case of need (for example, a par-
ticipant later requesting that their data be removed). Data
files including the full dataset will not include names to en-
sure confidentiality.
Discussion
Binge eating and related disorders are serious health con-
cerns that are associated with a number of psychosocial,
physical and occupational impairments (for example,
[58]). However, despite this and the risk of developing fur-
ther complications, many individuals with eating disorders
do not seek treatment. The results of this trial have the
potential to offer a more flexible approach to the treat-
ment of binge eating disorders, one that is patient-centred
and, possibly, more cost-effective than existing treatments.
A further aim is to evaluate the possibility of providing
supervision over the Internet for eating disorder interven-
tions, an idea that has not received much empirical atten-
tion, although some studies have used online supervision
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[59]). As is also suggested in the recent review of Aardoom
and colleagues [60], future studies would benefit from
investigating therapeutic alliance across face-to-face
and Internet-delivered treatments. Although some limita-
tions of the current design exist (for example, imperfect al-
location concealment, lack of blinding, lack of a placebo
control (see [31]), it is hoped that the results of this meth-
odology will produce high ecological and external validity,
as this (clinical) sample is recruited through a typical UK
healthcare service, and may be described as a ‘pragmatic
RCT’ [51].
Although Internet-delivered interventions have prom-
ise and appear to be highly acceptable ([60]; see also
[61]), there are many potential drawbacks. Some studies
report negative feedback regarding email communication
(for example, [7,62]), and individuals may require add-
itional commitment or motivation than a treatment requir-
ing face-to-face attendance. Further, although computer
literacy is increasing (that is, the “digital divide” is decreas-
ing; [63]), some individuals do not have access to the ne-
cessary materials that may be required for email therapy
(for example, [64,65]). As a number of authors have sug-
gested, it may be the case that ‘e-therapy’ is appropriate for
some, but not for others. It is hoped that the results of the
current trial might go some way towards supporting thera-
peutic equivalence for the two treatments, and thus give
patients more choice when accessing treatment.
Results of this study are hoped to inform different
ways of delivering the ‘first step’ of eating disorders care.
It aims to determine the relative effectiveness of email-
provided care compared to traditional face-to-face care
and a control condition. Furthermore, it aims to look at
novel methods of supervision and to evaluate the cost-
effectiveness of these interventions. In this way, it is hoped
that clear directions for future research and care provision
might be identified, ideally those that offer patients with
eating disorders the most effective treatments, in a man-
ner that suits them, with the best economic value.
Trial status
The trial is now recruiting (as of August 2013), and is
scheduled to continue until July 2017.
Additional file
Additional file 1: Measure to assess healthcare use.
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